A novel aminosterol reverses diabetes and fatty liver disease in obese mice

Keyphrases

• Diabetes 100%
• Hepatic Steatosis 100%
• Non-alcoholic Fatty Liver Disease (NAFLD) 100%
• Obese Mice 100%
• Fatty Liver Disease 100%
• Aminosteroid 100%
• Obesity 75%
• Insulin Resistance 75%
• Liver 50%
• Weight Loss 50%
• Food Restriction 50%
• Adiponectin 25%
• Effective Treatment 25%
• Energy Expenditure 25%
• Fatty Acid Oxidation 25%
• Food Intake 25%
• Alanine Aminotransferase Level 25%
• Weight Reduction 25%
• Fat Content 25%
• Liver Metabolism 25%
• Lipolysis 25%
• Insulin Action 25%
• Gene Expression Studies 25%
• Hepatic Fat 25%
• Lipolytic Enzymes 25%
• Triglyceride Synthesis 25%
• Circulating Lipids 25%
• Lipid Catabolism 25%
• Severe Insulin Resistance 25%
• Glucose/lipid Metabolism 25%
• Lipid Steatosis 25%
• Hepatic Lipid Synthesis 25%

Biochemistry, Genetics and Molecular Biology

• Insulin Resistance 100%
• Mouse Mutant 100%
• Enzyme 50%
• Lipid 50%
• Lipolysis 50%
• Body Weight 25%
• Gene Expression 25%
• Glucose Metabolism 25%
• Lipid Metabolism 25%
• Triglyceride 25%
• Lipogenesis 25%
• Liver Metabolism 25%
• Beta Oxidation 25%
• Energy Expenditure 25%
• Hyperlipidemia 25%
• Ob/Ob Mouse 25%
• Alanine Aminotransferase Level 25%
• Lipid Liver Level 25%
• Adiponectin 25%
• Glucose 25%
• Insulin 25%